Stemcell Assembloid; Biotechnology from Clinical source

 What began as research for Cilnical sources evolved into one of the biggest Medical device and hair care breakthroughs in Regeneration, Anti-aging,Whiten-ing, Lifting, Anti-wrinkle technology harnessed from Stem cell Assembloid.

 

- An Unexpected Stemcell Assembloid Source Discovery

 Stem cell Assembloid[MSC] is a Medical device and hair care brand delivering anti-aging innovation from Stem-cell Assembloid, one of the newest and most regeneration stemcell in the world.

The story of MSC is deeply rooted in biotechnology expertise from the heart of the biotechnology industry, Seoul Nat’L Univ. Biotechnology center and Kyounghee Univ. Skin Biotechnology center. Scientists behind the brand were studying Stem cell Assembloid as a source of medical sustainable when they came across an unexpected discovery that revolutionized the skincare industry.

 

- The Genius Of Stemcell Assembloid & Microbiom Bio-activity Substance.

 Well beyond its capacity to produce rich substance for various industry applications, specifically Plastic Surgery and Orthopedics. Stem cell Assembloid secrets a compound that not only allows it to survive, but thrive and regenerate in spite of exposure to the harshest Medical device. Scientists harnessed this compound and exposed it to rigorous scientific testing. They validated this compound's ability to help protect and regenerate the stem cell. This compound is Growth factor and Interleukin.

Stem cell Assembloid delivers unprecedented, scientifically measured Regeneration, Anti-aging,Whiten-ing, Lifting, Anti-wrinkle benefits to the skin. Patented for topical application it is found in all Medical device products.

 

- Cord Blood Stemcell Assembloid.

 Especially have hematopoietic stem cell. Cord blood-derived multipotent stem cell. A certain kind of cord blood stem cell (CB-SC) is multipotent and displays embryonic and hematopoietic characteristics. Phenotypic characterization demonstrates that (CB-SCs) display embryonic cell markers (e.g.,transcription factors OCT-4 and Nanog, stage-specific embryonic antigen (SSEA)-3, and SSEA-4) and leukocyte common antigen CD45, but that they are negative for blood cell lineage markers  (e.g., CD1a,  CD3,  CD4,  CD8, CD11b, CD11c, CD13, CD14, CD19, CD20, CD34, CD41a, CD41b, CD83, CD90, CD105, and CD133).

Additionally, CB-SCs display very low immunogenicity as indicated by expression of a very low level of major histocompatibility complex (MHC) antigens and failure to stimulate the proliferation of allogeneic lymphocytes. They can give rise to three embryonic layer-derived cells in the presence of different inducers. 

More specifically, CB-SCs tightly adhere to culture dishes with a large rounded morphology and are resistant to common detaching methods (trypsin/EDTA). CB-SCs are the active agent in stem cell educator therapy, which has therapeutic potential against autoimmune diseases like type 1 diabetes according to studies by Yong Zhao et al.

 

- Induced Pluripotent Stemcell Assembloid.

 These are not adult stem cells, but rather adult cells (e.g. epithelial cells) reprogrammed to give rise to pluripotent capabilities. Using genetic reprogramming with protein transcription factors, pluripotent stem cells equivalent to embryonic stem cells have been derived from human adult skin tissue. Shinya Yamanaka and his colleagues at Kyoto University used the transcription factors Oct3/4, Sox2, c-Myc, and Klf4 in their experiments on cells from human faces. Junying Yu, James Thomson, and their colleagues at the University of Wisconsin–Madison used a different set of factors, Oct4, Sox2, Nanog and Lin28, and carried out their experiments using cells from human foreskin.

As a result of the success of these experiments, Ian Wilmut, who helped create the first cloned animal Dolly the Sheep, has announced that he will abandon somatic cell nuclear transfer as an avenue of research.Frozen blood samples can be used as a source of induced pluripotent stem cells, opening a new avenue for obtaining the valued cells.